Teva Pharmaceutical Industries Ltd ADR buy Truist Financial Co.
Start price
29.01.26
/
50%
€27.00
Target price
29.01.27
€31.75
Performance (%)
16.67%
Price
17.08.26
€31.50
Summary
This prediction is currently active. The BUY prediction by Truist_Financial_Co_ currently has a performance of 16.67%. This prediction currently runs until 29.01.27. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Teva Pharmaceutical Industries Ltd ADR | 0.318% | 0.318% |
| iShares Core DAX® | 0,44 % | 5,90 % |
| iShares Nasdaq 100 | 1,06 % | 0,92 % |
| iShares Nikkei 225® | 1,77 % | 1,23 % |
| iShares S&P 500 | 0,37 % | 1,92 % |
Comments by Truist_Financial_Co_ for this prediction
In the thread Teva Pharmaceutical Industries Ltd ADR diskutieren
Teva Pharmaceutical Industries (NYSE:TEVA) had its price target raised by analysts at Truist Financial Corporation from $36.00 to $38.00. They now have a "buy" rating on the stock.
Ratings data for TEVA provided by MarketBeat
Stopped prediction by Truist_Financial_Co_ for Teva Pharmaceutical Industries Ltd ADR
Teva Pharmaceutical Industries Ltd ADR
Start price
Target price
Perf. (%)
€30.10
30.04.26
30.04.26
€38.57
30.04.27
30.04.27
4.65%
17.08.26
17.08.26
Teva Pharmaceutical Industries Ltd ADR
Start price
Target price
Perf. (%)
€28.90
18.02.26
18.02.26
€35.46
18.02.27
18.02.27
9.00%
17.08.26
17.08.26
Teva Pharmaceutical Industries Ltd ADR
Start price
Target price
Perf. (%)
€15.95
28.05.25
28.05.25
€22.09
28.05.26
28.05.26
82.45%
29.05.26
29.05.26